Open Access Endocrinology

Follow us for the latest open access endocrinology content from SAGE journals TAE and END, as well as general news items of interest.

[Open Access Endocrinology @OpenAccess_Endo]

We’re incredibly grateful to share that Therapeutic Advances in #Endocrinology & Metabolism has reached Q1 with a 2024 Impact Factor of 4.6! 🎉 This milestone reflects the passion and hard work of our amazing authors, editors, reviewers, and staff. https://t.co/5aDVcIMYnU

[Open Access Endocrinology @OpenAccess_Endo]

It's #DiabetesWeek 2025 💙 Time to make some noise, raise awareness, and shine a light on what life with diabetes really looks like — every single day. Sharing some resources about health checks for people with diabetes
@DiabetesUK
https://t.co/HCgLbtOait

[Royal Osteoporosis Society @RoyalOsteoSoc]

Today is World Multiple Sclerosis day.

If you or someone you love is living with MS, it's important to be aware of bone health, ask about your risk, and know that support is out there.
Check your risk today: https://t.co/JNaJ7296YF

#WorldMSDay #MultipleSclerosis #Osteoporosis

[Open Access Endocrinology @OpenAccess_Endo]

Special Collection: In-Hospital #DiabetesManagement & Characteristics. Deadline ending soon May 31, 2025 🚨 We’re seeking innovative contributions on Inpatient diabetes management, #Diabetescare technology, Oral #antidiabetics etc. 📝 More info https://t.co/ozqqsBoswk

[Therapeutic Advances in Cardiovascular Disease @TACardio]

📢 Call for Associate Editor!
SAGE is seeking a new Associate Editor for Therapeutic Advances in Cardiovascular Disease.
🔍 Expertise: Interventional Cardiology
📅 Term: 3 years, starting end of 2025
📩 Apply now https://t.co/iFjRgIrneI

[Alejandro Roman-Gonzalez @alejoromanmd]

Systemic therapies for medullary thyroid carcinoma: state of the art - Alejandro Román-González, Ines Califano, Marcio Concepción-Zavaleta, Fabian Pitoia, Sarimar Agosto Salgado, 2025 https://t.co/TSa7oakooM

[Open Access Endocrinology @OpenAccess_Endo]

📉 Study from #Duke-NUS Medical School & Singapore General Hospital reveals that the timing of inpatient #hypoglycaemia in diabetes patients is strongly linked to the type of treatment given. This work helps personalise care for #diabetes patients. https://t.co/IuzOj3HJWf

[World Obesity Day @WorldObesityDay]

🚦 Over 3.5 million deaths annually are linked to high BMI. Addressing obesity is critical to reducing the burden of NCDs.

➡️ Get involved :https://t.co/0Jyf6xAKxG
#WorldObesityDay ⭕ #ChangingSystems #HealthierLives

[Open Access Endocrinology @OpenAccess_Endo]

As World Hormone Day approaches, we are proud to support this global initiative by raising awareness about the importance of hormone health. We're committed to sharing expert insights to highlight the critical role hormones play in overall well-being. https://t.co/g35nBmnd0V

[Diabetes UK @DiabetesUK]

The Journey of Insulin🚀

From its discovery 103 years ago to today’s cutting-edge innovations, insulin has transformed millions of lives.

Explore how the #Type1DiabetesGrandChallenge is driving research into the future of diabetes treatment.

🔗https://t.co/OfEAv00Xhg
#GBDoc

[Open Access Endocrinology @OpenAccess_Endo]

We’re seeking research on Technology in Type 1 #Diabetes management! Share your insights on #CGMs, insulin pumps, AID systems, smart pens, telehealth, and more. Help shape the future of diabetes care. @Ahmed742Iqbal @sribellary https://t.co/dEvxm7zsMF

[Open Access Endocrinology @OpenAccess_Endo]

🙏 On behalf of the Therapeutic Advances in Endocrinology and Metabolism editorial team, we extend our sincere gratitude to all the #reviewers who dedicated their time and expertise in 2024. https://t.co/Io89satLbt🌟 #TAEM #PeerReview #ThankYou

[elsadiabetes @elsadiabetes]

Join the UK's first Type I Diabetes Early Detection Summit

This 2-day conference will cover the practicalities of and science underpinning the screening, monitoring and treatment of early T1D

9-10th June 2025

Register here
https://t.co/U7r23vuFp4

@ABCDiab @BritSPED @ACDC_UK

[Open Access Endocrinology @OpenAccess_Endo]

Don’t miss it – we’re pleased to share our first Plain Language Summary of Publication (PLSP) article. Click the link and download today! https://t.co/3Y1JdskMOG

#PlainLanguageSummary #growthhormone #deficiency @Pfizer_UK

[Open Access Endocrinology @OpenAccess_Endo]

📝 Available to read: Exploring the anti-inflammatory role of glucagon-like peptide 1 (GLP-1) receptor agonists and their clinical implications! Could these therapies offer a new path for managing inflammation? https://t.co/cIogLEYzjk

[World Obesity Day @WorldObesityDay]

🌍 Today is #WorldObesityDay ⭕️!

Obesity rates are rising—not because of individual choices, but due to failing systems. It’s time for systemic change in health, food, and societal systems.

📢 Join us in calling for action! 👉 https://t.co/lxgQev64ur

#WOD2025 #ChangingSystems

[Diabetes UK Research @DUK_research]

It’s standing room only at #DUKPC to hear from the @ExeterMed team behind the beautiful new predictive tool designed to identify which blood glucose-lowering drug will be most effective for each individual with #type2diabetes.

[Diabetes UK Research @DUK_research]

Congrats to Katy Murrall @katymurrall for winning this year’s Diabetes UK Basic Science Poster Award💙🥳

[Open Access Endocrinology @OpenAccess_Endo]

An update on @ABCDiab activity by Dr. @ketandhatariya

[Diabetes UK Research @DUK_research]

Next up on the stage of #DUKPC: Professor Ines Barroso @InesBarroso4 shares insights from her #research journey, showing how her expertise in genetics is helping to answer key questions for people living with #diabetes— all in her inspiring Dorothy Hodgkin Lecture. 🧬